KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$3.8 million.

  • Cardlytics' Non Operating Income fell 17885.61% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 11558.0%. This contributed to the annual value of $6.2 million for FY2024, which is 8750.0% up from last year.
  • Latest data reveals that Cardlytics reported Non Operating Income of -$3.8 million as of Q3 2025, which was down 17885.61% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Non Operating Income ranged from a high of $11.6 million in Q2 2024 and a low of -$7.3 million during Q4 2024
  • For the 5-year period, Cardlytics' Non Operating Income averaged around -$365526.3, with its median value being -$2.6 million (2022).
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 1529000.0% in 2021, then surged by 73189.34% in 2024.
  • Quarter analysis of 5 years shows Cardlytics' Non Operating Income stood at -$3.3 million in 2021, then soared by 232.4% to $4.4 million in 2022, then rose by 1.52% to $4.4 million in 2023, then plummeted by 264.52% to -$7.3 million in 2024, then skyrocketed by 47.51% to -$3.8 million in 2025.
  • Its last three reported values are -$3.8 million in Q3 2025, $5.4 million for Q2 2025, and $2.6 million during Q1 2025.